CoChat

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Myoinositol versus metformin pretreatment in GnRH-antagonist cycle for women with PCOS undergoing IVF: a double-blinded randomized controlled study

Abstract

OBJECTIVE: To study the effects of myoinositol (Myo) in comparison to metformin (Met), in reducing the risk of OHSS and improving ART outcome in PCOS women undergoing IVF. DESIGN: Double-blinded randomized controlled trial (CTRI/2018/05/014196). SETTING: ART Clinic, AIIMS, New Delhi patients: 102 infertile PCOS women undergoing IVF cycles were enrolled after evaluating for eligibility and allotted as 50 in group 1 (Myo) and 52 in group 2 (Met) after randomization. INTERVENTIONS: Recruited patients received Myo 2 g twice daily (group 1) and Met 850 mg twice daily (group 2). Pre- and post-treatment clinical (menstrual pattern, BMI), hormonal profile (LH, FSH, testosterone, prolactin [PRL], and AMH), biochemical parameters (HOMA IR, fasting glucose, and insulin), ovarian with antral follicle count (AFC) and side effect profile were assessed. After 3 months of therapy, patients were recruited for IVF cycle by antagonist protocol was involving controlled ovarian stimulation, cycle monitoring, oocyte recovery, insemination of oocytes and follow up with fertilization, cleavage, transfer of good grade cleavage embryos, or blastocysts pregnancy outcomes and OHSS incidence and medications was continued until the day of OPU. MAIN OUTCOME MEASURES: Primary outcome was OHSS and clinical pregnancy rate including spontaneous, IVF, and cumulative pregnancy rate including FET. Secondary outcome was ART outcomes and the change in biochemistry and hormonal profile between groups and inter group after medications at 12 weeks. RESULTS: .07) was significantly high in Myo group. No between group difference in ovarian stimulation outcomes including duration and dosage of gonadotropins, E2, P4 levels, number of follicles >14 mm on day of trigger. Number of oocytes retrieved and grade of maturity were similar between groups. Fertilization, cleavage and number of good grade embryos were significantly higher in Myo group. However, implantation rate and number of embryos for freezing were similar between groups. Myo had improvement in fasting insulin, HOMA, Sr.AMH, and SHBG suggesting decreased insulin resistance. CONCLUSIONS: Myo is equally beneficial as Met in reducing the risk of OHSS and has better ART outcome in PCOS women undergoing antagonist cycles.

Overview

Integrity signals

Registry

Crossref · 10.1080/09513590.2021.1981282

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

12 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

1 retracted

Show all 18 references

Research works printed but not linked: 5

  1. Tso LO, 2014, Cochrane Database Syst Rev, CD006105
  2. Showell MG, 2018, Cochrane Database Syst Rev, 12, CD012378
  3. Smith V, 2020, Obstet Gynecol Int, 2015, 12
  4. Mourad S, 2017, Cochrane Database Syst Rev, 1, CD012103
  5. Morley LC, 2017, Cochrane Database Syst Rev, 11, CD003053

Cited by

See all 22

Metadata

Authors
Rajasekaran, K., Malhotra, N., Mahey, R., Khadgawat, R., & Kalaivani, M.
Affiliations
All India Institute of Medical Sciences (IN)
Corresponding author
Malhotra, Neena
Venue
Gynecological Endocrinology
Published
2021-09-30
Volume
38
Issue
2
Pages
140-147
ISSN
  • 0951-3590 (ISSN-L)
  • 1473-0766
OpenAlex
W3203102447
Cited by
22
References
18
Citations by year
2026: 4 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 1
FWCI
2.37
Type
journal article
Language
en
Open access
closed
Locations
  • Gynecological Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
Keywords
myo-inositol, metformin, polycystic ovary syndrome, in vitro fertilization, GnRH antagonist protocol, ovarian hyperstimulation syndrome, insulin resistance, HOMA-IR, androgen-binding protein, antral follicle count, clinical pregnancy rate, embryo quality, controlled ovarian stimulation, assisted reproduction outcomes, insulin sensitizers, insulin-mimetic agents
MeSH terms
Female, Fertilization in Vitro, Humans, Inositol, Gonadotropin-Releasing Hormone, Metformin, Ovulation Induction, Polycystic Ovary Syndrome, Pregnancy, Ovarian Hyperstimulation Syndrome, Pregnancy Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myoinositol versus metformin pretreatment in GnRH-antagonist cycle for women with PCOS undergoing IVF: a double-blinded randomized controlled study. https://app.cochat.ai/papers/10.1080/09513590.2021.1981282
The paper
Rajasekaran, K., Malhotra, N., Mahey, R., Khadgawat, R., & Kalaivani, M. (2022). Myoinositol versus metformin pretreatment in GnRH-antagonist cycle for women with PCOS undergoing IVF: a double-blinded randomized controlled study. Gynecological Endocrinology. https://doi.org/10.1080/09513590.2021.1981282

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.